Matregenix utilizes a proprietary nanofiber platform technology to develop implants for soft tissue regeneration The company has been self sustained through offering custom contract development for the medical device and drug delivery industry The Company is integrated with strong IP portfolio with 8 filed patents, a defined regulatory pathway, and a team of experts in material science and engineering